What we're reading, December 14, 2016: many Obamacare enrollees voted for Donald Trump expecting him to fix, not repeal, the law; President Barack Obama signs 21st Century Cures Act into law; Ohio Governor John Kasich vetoes one abortion bill, signs another.
People who have enrolled for healthcare insurance through the Affordable Care Act (ACA) and voted for Donald Trump did so because they expected him to fix, not repeal, the law. According to Vox’s Sarah Kliff, who spent time in Kentucky interviewing Trump supporters, people were frustrated with the rising cost of premiums and deductibles and the idea that other people were getting better, cheaper benefits. They all believed that Trump would fix the problems they saw with the ACA and that he wouldn’t really repeal the law.
President Barack Obama has signed the 21st Century Cures Act into law. The bill invests $1.8 billion in Vice President Joe Biden’s Cancer Moonshot program and includes an $6.3 billion in new spending overall in the next 10 years. While the bill represents a rare example of bipartisanship, patient advocacy groups remain opposed to it, reported the AP. They believe the bill weakens FDA oversight. At the signing, Obama touted the benefits of the ACA in the hope that Congress will continue its bipartisan work and keep the bill.
In Ohio, Governor John Kasich vetoed one abortion bill only to sign into law another, less restrictive abortion bill. According to The Washington Post, Kasich vetoed the controversial “heartbeat bill” that would ban abortion as early as 6 weeks—before most women know they are pregnant. However, he did sign a bill that banned the procedure at 20 weeks. The newly signed law conflicts with previous Supreme Court decisions, which tend to uphold abortion rights until around 24 weeks.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen